On Thursday, in the course of current trade, Shares of Micron Technology, Inc. (NASDAQ:MU), gained 1.53%, and is now trading at $28.56.
Micron Technology, Inc. (MU) President Mark Adams presented Wednesday, May 27, at the 31st annual Sanford C. Bernstein Planned Decisions Conference 2015.
Micron Technology, Inc., together with its auxiliaries, provides semiconductor solutions worldwide. The company manufactures and markets dynamic random access memory (DRAM), NAND flash, and NOR flash memory products; and packaging solutions and semiconductor systems.
During Morning trade, Shares of Marvell Technology Group Ltd. (NASDAQ:MRVL), gained 0.61%, and is now trading at $13.99.
Marvell Technology Group, stated financial results for the first quarter of fiscal year 2016, ended May 2, 2015.
Key First Quarter of Fiscal 2016 Financial Highlights
- Revenue: Q1 FY 2016, $724 Million
- GAAP Net Income: Q1 FY 2016, $14 Million
- GAAP Diluted EPS: Q1 FY 2016, $0.03
- Non-GAAP Net Income: Q1 FY 2016, $71 Million
- Non-GAAP Diluted EPS: Q1 FY 2016, $0.13
- Free Cash Flow: Q1 FY 2016, $44 Million
Marvell Technology Group Ltd. designs, develops, and markets analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits. It offers mobile and wireless products comprising communications and applications processors; thin modems; and connectivity solutions, counting Wi-Fi, Bluetooth, near field communication, and FM; and mobile computing products, in addition to silicon solutions and Kinoma software.
Shares of Great Basin Scientific, Inc. (NASDAQ:GBSN), during its Thursday’s current trading session fell -0.53%, and is now trading at $3.75.
Great Basin Scientific, declared continued expansion of the customer base utilizing the Great Basin sample-to-result molecular diagnostic technology during April and May. The Company stated a total of 112 revenue-generating customers in the United States as of May 27, 2015, a 10.3% enhance over the 101 customers stated as of the preceding quarter ending March 31, 2015. Active and planned customer evaluations, representing the Company’s sales pipeline, are 44 as of May 27.
Great Basin Scientific, Inc., a molecular diagnostic testing company, doing business as Great Basin Corporation, develops and commercializes molecular diagnostic systems that are designed to test hospital-attained infections. The company’s platform provides C. diff test, a rapid medical diagnostic test for the detection of C. diff, a gram-positive bacteria that causes severe diarrhea and other intestinal disorders.
Finally, IMRIS, Inc. (NASDAQ:IMRS), lost -14.19% Thursday, hitting its lowest level.
IMRIS, declared that the Company, its partner NeuroArm Surgical Ltd., and its U.S. partner, IMRIS, Inc. have each filed voluntary petitions under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
As part of the filing, IMRIS declared that subject to a marketing process and Court approval, it intends to sell its business operations to an associate of Deerfield Administration Company, L.P. (“Deerfield”). In addition, the Company has secured a commitment for debtor-in-possession financing from Deerfield, which, in addition to IMRIS’s ongoing cash flow, will ensure it is able to continue meeting its financial obligations throughout the Chapter 11 case. During this time, IMRIS intends to conduct a marketing process for its operating businesses.
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
